Skip to main content
. 2020 Sep 11;10:1765. doi: 10.3389/fonc.2020.01765

Figure 7.

Figure 7

Correlation analysis between TYROBP, C1QB, and immune factors, including immune cells and biomarkers for immunotherapy. (A) Correlation between TYROBP, C1QB, and the immune cells in the TIMER database. (B) Survival analysis of the immune cells in the TIMER database. (C) Correlation between TYROBP, C1QB, and the immune cells in the TCGA-STAD dataset. (D) Correlation between TYROBP, C1QB, and the immune cytolytic activity in the TCGA-STAD dataset. (E) Correlation between TYROBP, C1QB, and the immune checkpoints in the TCGA-STAD dataset. (F) Correlation between TYROBP, C1QB and the immune checkpoints in the GSE51575 dataset. (G) Relative expression of TYROBP and C1QB in the four molecular subtypes in the TCGA-STAD dataset. (H) Relative expression of TYROBP and C1QB in normal tissues, EBV negative (–) and positive (+) GC tissues in the GSE51575 dataset. R1, the correlation coefficient between TYROBP and the immune factors; R2, the correlation coefficient between C1QB and the immune factors; GC, gastric cancer. The data marked red color is statistically significant. ***P < 0.001, ****P < 0.0001.